Psyomics is a UK-based startup focusing on utilizing technology to expedite mental health support. Led by CEO Dr. Melinda Rees, the company aims to revolutionize mental health assessment, diagnosis, triage, and treatment. Established in 2015 as a spinout from Cambridge University Biotech, Psyomics was founded by Professor Sabine Bahn, the Laboratory Director at the Cambridge Centre for Neuropsychiatric Research. After six years of research and development, the company launched CENSEO in late 2022, a digital platform that significantly reduces clinical triage and assessment time for over 15 mental health conditions, with more than 6,500 patients using it to date. In June 2024, Psyomics secured a £4.00M Venture Round investment from Parkwalk Advisors, signaling confidence in its potential to make a significant impact in the biotechnology, education, and healthcare industries.
Psyomics
Technology to help people get the mental health support they need sooner.
Cambridge, United Kingdom
23 employees
Venture round
Total: $9.05M
Biotechnology, Education +1
General Information
Cambridge, United Kingdom
BounceWatch is an independent company data service, not affiliated with Psyomics. To contact Psyomics, visit psyomics.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
Discover More
United Kingdom Market
Biotechnology
About Psyomics
Taxonomy: mental health, technology, assessment platform, clinical expertise, Cambridge University, neuropsychiatric research, psychiatry, digital health, referral pathways, clinical technology, support, mental health conditions, psychiatric assessment, research-driven
Funding Rounds & Investors (8)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Venture Round | £4.00M | 1 |
|
05 Jun 2024 |
| Venture Round | Undisclosed | 1 |
|
31 Aug 2022 |
| Venture Round | £2.50M | 1 |
|
18 Jan 2022 |
| Venture Round | £1.50M | 1 |
|
27 Oct 2020 |
| Series B | Undisclosed | 1 |
|
24 Jun 2019 |
| Venture Round | Undisclosed | - |
|
12 Sep 2017 |
| Series A | $1.00M | 3 |
|
15 Jun 2016 |
| Grant | €50.00K | 1 |
EASME - EU Executive Agency for SMEs
|
01 Mar 2016 |
Psyomics Alternatives & Competitors
View All Alternatives
We’re on a mission to revolutionize mental healthcare
New hope for anorexia nervosa
FAQ About Psyomics
Source: BounceWatch company record for Psyomics, https://bouncewatch.com/company/psyomics, updated 25 November 2024. When citing, please name BounceWatch and link this page.
